Spruce Biosciences (SPRB) Earnings Date & Reports

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders withÂ unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRB is expected to report earnings to -20 cents per share on March 31

Spruce Biosciences SPRB Stock Earnings Reports

Q4'24

Est.

$-0.21

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.10

Q1'24

Beat

by $0.08

Q4'23

Beat

by $0.17

The last earnings report on November 11 showed earnings per share of -20 cents, beating the estimate of -23 cents. With 556.78K shares outstanding, the current market capitalization sits at 12.10M.

View a ticker or compare two or three

Compare

SPRB